Article Text

Download PDFPDF
Robotic Uterine Artery Preservation and Nerve-Sparing Radical Trachelectomy With Bilateral Pelvic Lymphadenectomy in Early-Stage Cervical Cancer
  1. Dae Gy Hong, MD, PhD,
  2. Yoon Soon Lee, MD, PhD,
  3. Nae Yoon Park, MD,
  4. Gun Oh Chong, MD,
  5. Il Soo Park, MD, PhD and
  6. Young Lae Cho, MD, PhD
  1. Department of Obstetrics and Gynecology, Kyungpook National University, Graduate School of Medicine, Daegu, Korea.
  1. Address correspondence and reprint requests to Yoon Soon Lee, MD, PhD, Department of Obstetrics and Gynecology, Kyungpook National University Hospital, Daegu, South Korea 721-700. E-mail: yslee{at}knu.co.kr.

Abstract

Objective: The aim of the study was to evaluate the safety and feasibility of robotic uterine artery preservation and nerve-sparing radical trachelectomy with pelvic lymphadenectomy using the da Vinci surgical system.

Methods: Three patients who were diagnosed with early-stage cervical cancer underwent robotic uterine artery preservation and nerve-sparing radical trachelectomy with bilateral lymphadenectomy from January 2010 to March 2010. The data were compared with those of 4 cases of total laparoscopic nerve-sparing radical trachelectomy that were performed from July 2004 to May 2005 and were previously reported.

Results: In the robotic group, the mean console time was 275 minutes (range, 240-305 minutes). The mean postoperative hemoglobin change was 0.4 g/dL (range, 0.2-0.6 g/dL). The mean estimated blood loss was 23 mL (range, 15-40 mL), which is less than that of the laparoscopic group. There were no metastases detected in any of the cases, and the resection margins were negative in both groups.

Conclusions: The robotic uterine artery preservation and nerve-sparing radical trachelectomy with pelvic lymphadenectomy were efficient in reducing blood loss and feasible methods such as other approaches.

  • Cervical carcinoma
  • Robotic surgery
  • Trachelectomy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.